Quantinno Capital Management LP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1759654
NEW YORK, NY
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$653,278
+$182,409 QoQ
Shares Held
32,453
+11.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 182 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quantinno Capital Management LP holds $387,058,900 across 157 Biotechnology names. KALV ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
126,604 | $56,533,750 | |
| 2 | TECH |
BIO-TECHNE Corp
|
814,322 | $42,556,467 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,251 | $37,280,652 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
191,286 | $36,162,618 | |
| 5 | RPRX |
Royalty Pharma plc
|
382,571 | $18,351,930 | |
| 6 | INCY |
Incyte Corp
|
158,226 | $14,892,231 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,850 | $11,199,949 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
138,547 | $8,954,292 |
All Filings in KALV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $653,278 | 32,453 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $470,869 | 29,156 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $172,444 | 14,158 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||